LGHT vs. IDNA
LGHT (Langar Global HealthTech ETF) and IDNA (iShares Genomics Immunology and Healthcare ETF) are both Health & Biotech Equities funds. LGHT is actively managed, while IDNA is passively managed. Over the past year, LGHT returned -12.37% vs 54.17% for IDNA. Their 0.58 correlation means they have sometimes moved together and sometimes differently. LGHT charges 0.85%/yr vs 0.47%/yr for IDNA.
Performance
LGHT vs. IDNA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, LGHT achieves a -10.75% return, which is significantly lower than IDNA's 26.17% return.
LGHT
- 1D
- 0.51%
- 1M
- -0.65%
- 6M
- -6.77%
- YTD
- -10.75%
- 1Y
- -12.37%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- -4.87%
IDNA
- 1D
- 1.50%
- 1M
- -5.74%
- 6M
- 14.46%
- YTD
- 26.17%
- 1Y
- 54.17%
- 3Y*
- 14.74%
- 5Y*
- -8.69%
- 10Y*
- —
- ALL TIME*
- 5.00%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $819.25K | $1.37M | $1.50M | |
| $40.81K | $22.59K | $17.37K |
LGHT vs. IDNA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
LGHT Langar Global HealthTech ETF | -10.75% | -1.66% | 0.23% |
IDNA iShares Genomics Immunology and Healthcare ETF | 26.17% | 17.26% | -3.82% |
Correlation
The correlation between LGHT and IDNA is 0.53, which is moderate. They have sometimes moved together and sometimes differently, sharing some price drivers without tracking each other closely.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.53 |
Correlation (All Time) Calculated using the full available price history since Jan 10, 2024 | 0.58 |
The correlation between LGHT and IDNA has been stable across timeframes, ranging from 0.53 to 0.58 - a consistent structural relationship.
LGHT vs. IDNA - Sectors Allocation Comparison
Sectors
LGHT
IDNA
Healthcare
Technology
-
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
-
Industrials
-
Real Estate
-
-
Utilities
-
-
Healthcare
LGHT
IDNA
Technology
LGHT
IDNA
-
Basic Materials
LGHT
-
IDNA
-
Communication Services
LGHT
-
IDNA
-
Consumer Cyclical
LGHT
-
IDNA
-
Consumer Defensive
LGHT
-
IDNA
-
Energy
LGHT
-
IDNA
-
Financial Services
LGHT
-
IDNA
-
Industrials
LGHT
-
IDNA
Real Estate
LGHT
-
IDNA
-
Utilities
LGHT
-
IDNA
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
LGHT vs. IDNA — Risk / Return Rank
LGHT
IDNA
LGHT vs. IDNA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Langar Global HealthTech ETF (LGHT) and iShares Genomics Immunology and Healthcare ETF (IDNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| LGHT | IDNA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.80 | ||
| Sortino ratioReturn per unit of downside risk | -3.78 | ||
| Omega ratioGain probability vs. loss probability | 0.91 | 1.34 | -0.43 |
| Calmar ratioReturn relative to maximum drawdown | -0.49 | 5.10 | -5.59 |
| Martin ratioReturn relative to average drawdown | -0.91 | 13.36 | -14.27 |
Loading charts...
Drawdowns
LGHT vs. IDNA - Drawdown Comparison
The maximum LGHT drawdown since its inception was -28.60%, smaller than the maximum IDNA drawdown of -68.26%. Use the drawdown chart below to compare losses from any high point for LGHT and IDNA.
Loading charts...
Drawdown Indicators
| LGHT | IDNA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -28.60% | -68.26% | +39.66% |
Max Drawdown (1Y)Largest decline over 1 year | -25.57% | -10.66% | -14.91% |
Max Drawdown (3Y)Largest decline over 3 years | — | -29.46% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -68.26% | — |
Current DrawdownCurrent decline from peak | -19.76% | -37.79% | +18.03% |
Average DrawdownAverage peak-to-trough decline | -8.60% | -36.30% | +27.70% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 13.69% | 4.07% | +9.62% |
Volatility
LGHT vs. IDNA - Volatility Comparison
Langar Global HealthTech ETF (LGHT) has a higher volatility of 8.02% compared to iShares Genomics Immunology and Healthcare ETF (IDNA) at 5.98%. This indicates that LGHT's price experiences larger fluctuations and is considered to be riskier than IDNA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| LGHT | IDNA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.02% | 5.98% | +2.04% |
Volatility (6M)Calculated over the trailing 6-month period | 16.64% | 18.14% | -1.50% |
Volatility (1Y)Calculated over the trailing 1-year period | 20.28% | 24.93% | -4.65% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 19.45% | 28.48% | -9.03% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 19.45% | 29.43% | -9.98% |
LGHT vs. IDNA - Expense Ratio Comparison
LGHT has a 0.85% expense ratio, which is higher than IDNA's 0.47% expense ratio.
Dividends
LGHT vs. IDNA - Dividend Comparison
LGHT has not paid dividends to shareholders, while IDNA's dividend yield for the trailing twelve months is around 0.85%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
IDNA iShares Genomics Immunology and Healthcare ETF | 0.85% | 1.18% | 0.98% | 1.04% | 0.54% | 0.70% | 0.26% | 0.80% |
LGHT Langar Global HealthTech ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
LGHT and IDNA have a correlation of 0.53, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
LGHT has higher volatility (8.02%) compared to IDNA (5.98%). In terms of maximum drawdown, LGHT dropped -28.60% vs IDNA's -68.26%.
On 1-year performance, IDNA leads with 54.17% vs -12.37% for LGHT. On fees, IDNA is cheaper at 0.47% per year. On volatility, IDNA has been the lower-risk option at 5.98%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 1-year period, IDNA has performed better with a 54.17% return vs -12.37%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
IDNA is cheaper with a 0.47% expense ratio, compared with 0.85% for LGHT.
IDNA has the higher dividend yield at 0.85%, compared with 0.00% for LGHT.
They also come from different issuers: Langar and iShares. Their fees differ too: 0.85% for LGHT and 0.47% for IDNA.
IDNA currently has the higher Sharpe Ratio (2.19 vs -0.61), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for LGHT and IDNA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer